Literature DB >> 24402743

Occlusion therapy in amblyopia: an experience from Hong Kong.

Emily W H Tang1, Brian C Y Li, Ian Y L Yeung, Kenneth K W Li.   

Abstract

OBJECTIVES. To review the results of patching for amblyopia management in Hong Kong. DESIGN. Retrospective case series. SETTING. Regional hospital, Hong Kong. PATIENTS. Records of all patients attending Paediatric Ophthalmology Clinic at United Christian Hospital, Hong Kong from 1 January 2009 to 31 March 2009 were retrospectively reviewed. Records of all children who underwent patching for amblyopia in the study period were evaluated. RESULTS. The mean age of 50 children (50 eyes) was 4 (standard deviation, 1; range, 2-7) years and mean pretreatment visual acuity was 0.35 (0.15; 0.02-0.63) [~20/60]. The values for mean, standard deviation, and range of treatment duration were 27, 16, 4-67 months respectively, and corresponding values for prescribed patching per day were 4, 1, 2-8 hours. The mean, standard deviation, and range of visual acuity at final post-treatment assessment were 0.66, 0.16, 0.1-1.0 (~20/30), respectively. The overall success rate (ie final visual acuity >0.7 or 20/30) was 62%. Children with moderate amblyopia (20/40-20/80) and severe amblyopia (20/100-20/400) had success rates of 74% and 55%, respectively. The mean visual acuity improvements for moderate and severely amblyopic children were 2.3 lines and 5.8 lines, respectively. The mean, standard deviation, and range of patching prescriptions for moderate and severely amblyopic children were 5, 1, 2-7 hours and 5, 1, 3-6 hours, respectively. Recurrence ensued in 7% of the children with moderate amblyopia and 46% of those with severe amblyopia. Reported compliance was good (>75% of the time) in 68% of the children. CONCLUSION. Occlusion therapy is the mainstay of treatment in Hong Kong. The overall success rate was comparable to that achieved in the Amblyopia Treatment Study. Recurrence was more common in patients with severe amblyopia, for whom maintenance therapy may reduce the risk of recurrence. The duration of treatment was much longer in our locality than in western countries. Reported compliance was suspicious possibly due to traditional cultural contexts. It is important to emphasise compliance to all parents.

Entities:  

Keywords:  Amblyopia; Hong Kong; Treatment outcome

Mesh:

Year:  2014        PMID: 24402743     DOI: 10.12809/hkmj133952

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  3 in total

1.  Efficiency of the occlusion therapy with and without levodopa-carbidopa in amblyopic children-A tertiary care centre experience.

Authors:  Ishfaq Ahmad Sofi; Satish K Gupta; Anuradha Bharti; Tariq G Tantry
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

2.  New treatment for amblyopia based on rules of synaptic plasticity: a randomized clinical trial.

Authors:  Xin Huang; Huika Xia; Qi Zhang; Yan Nan; Wenyao Wang; Colin Blakemore; Jie Gao; Spencer S Ng; Jing Wen; Tiejun Huang; Xiaoqing Li; Mingliang Pu
Journal:  Sci China Life Sci       Date:  2022-01-06       Impact factor: 6.038

3.  Long-Term Efficacy of the Combination of Active Vision Therapy and Occlusion in Children with Strabismic and Anisometropic Amblyopia.

Authors:  Myriam Milla; Ainhoa Molina-Martín; David P Piñero
Journal:  Children (Basel)       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.